Whitton, K., Baber, R. (2024). Androgen-based therapies in women. Best Practice and Research: Clinical Endocrinology and Metabolism, 38(1), 101783. [More Information]
Whitton, K., Baber, R. (2024). Menopausal hormone therapy: Tips and pitfalls. Medicine Today, 25(9), 2-7.
Evans, S., Baber, R., Satyen, L., Skvarc, D., Mikocka-Walus, A., Van Niekerk, L., Orellana, L., O'shea, M., Druitt, M., Jones, S., et al (2024). The need for biopsychosocial menopause care: a narrative review. Menopause. [More Information]
Hickey, M., Baber, R., Eden, J., Brennan, J., Bateson, D., Goldman, M. (2023). Safety and effectiveness of a novel home-use therapeutic ultrasound device for the treatment of vaginal dryness in postmenopausal women: a pilot study. Menopause, 30(4), 383-392. [More Information]
Yang, C., Eykman, E., Smith, C., Bacon, J., Morris, J., Baber, R., Seeho, S. (2023). Vernix Caseosa Peritonitis Causing Acute Abdomen After Cesarean Section: A Case Series. The American Journal of Case Reports, 24. [More Information]
Magraith, K., Stuckey, B., Baber, R. (2022). Perimenopausal hormone therapy Assessment and prescribing. Medicine Today, 23(8), 61-66.
Ibiebele, I., Nippita, T., Baber, R., Torvaldsen, S. (2022). Pregnancy outcomes in women with endometriosis and/or ART use: a population-based cohort study. Human Reproduction, 37(10), 2350-2358. [More Information]
Vrselja, A., Latifi, A., Baber, R., Stuckey, B., Walker, M., Stearns, V., Hickey, M., Davis, S. (2022). Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet, 400(10364), 1704-1711. [More Information]
Davis, S., Baber, R. (2022). Treating menopause — MHT and beyond. Nature Reviews Endocrinology, 18(8), 490-502. [More Information]
Ibiebele, I., Nippita, T., Baber, R., Torvaldsen, S. (2021). A study of pregnancy after endometrial ablation using linked population data. Acta Obstetricia et Gynecologica Scandinavica, 100(2), 286-293. [More Information]
Davis, S., Stuckey, B., Magraith, K., Baber, R. (2021). Letter to the Editor: "Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline". Journal of Clinical Endocrinology and Metabolism, 106(4), e1917-e1918. [More Information]
Rowe, I., Baber, R. (2021). The effects of phytoestrogens on postmenopausal health. Climacteric, 24(1), 57-63. [More Information]
Baber, R. (2021). Treating menopausal women: Have we lost our way? Australian and New Zealand Journal of Obstetrics and Gynaecology, 61(4), 493-495. [More Information]
de Villiers, T., Baber, R. (2021). Using menopausal hormone therapy to prevent fracture recurrence in older women: is it time to change our opinion? Climacteric, 24(4). [More Information]
Davis, S., Baber, R., Panay, N., Pinkerton, J. (2020). Author's response to Letter to the Editor: Global Consensus Position Statement on the Use of Testosterone Therapy for Women"". Journal of Clinical Endocrinology and Metabolism, 105(6), dgaa126. [More Information]
Davis, S., Baber, R., Panay, N., Bitzer, J., Perez, S., Islam, R., Kaunitz, A., Kingsberg, S., Lambrinoudaki, I., Liu, J., et al (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Sexual Medicine, 16(9), 1331-1337. [More Information]
Davis, S., Baber, R., Panay, N., Bitzer, J., Cerdas Perez, S., Islam, R., Kaunitz, A., Kingsberg, S., Lambrinoudaki, I., Liu, J., et al (2019). Global Consensus Position Statement on the use of Testosterone Therapy for Women. Maturitas, 128, 89-93. [More Information]
Davis, S., Baber, R., Panay, N., Bitzer, J., Cerdas Perez, S., Islam, R., Kaunitz, A., Kingsberg, S., Lambrinoudaki, I., Liu, J., et al (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology and Metabolism, 104(10), 4660-4666. [More Information]
Davis, S., Baber, R., Panay, N., Bitzer, J., Cerdas Perez, S., Islam, R., Kaunitz, A., Kingsberg, S., Lambrinoudaki, I., Liu, J., et al (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Climacteric, 22(5), 429-434. [More Information]
Baber, R. (2019). Premature menopause managing the long-term consequences. Medicine Today, 20(3), 45-47.
Baber, R. (2018). Editor’s comment. Climacteric, 21(2), 197-197. [More Information]
Phua, C., Baber, R. (2018). The Management of Menopausal Symptoms in Women Following Breast Cancer: An Overview. Drugs & Aging, 35(8), 699-705. [More Information]
Baber, R. (2018). What's new in menopausal hormone therapy: Combination oestrogen-bazedoxifene. Medicine Today, 19(4), 47-50.
Baber, R., Wright, J. (2017). A brief history of the International Menopause Society. Climacteric, 20(2), 85-90. [More Information]
Clifton-Bligh, P., Nery, M., Clifton-Bligh, R., Fulcher, G., Baber, R. (2017). Changes in bone mineral density related to changes in serum 25-OH vitamin D concentrations over a two-year period in postmenopausal women. Endocrine, 58(3), 587-590. [More Information]
Mazza, D., Bateson, D., Frearson, M., Goldstone, P., Kovacs, G., Baber, R. (2017). Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion. Australian and New Zealand Journal of Obstetrics and Gynaecology, 57(2), 206-212. [More Information]
Baber, R. (2017). Hormone therapy and menopause A protracted misunderstanding explained. Medicine Today, 18(2), 23-26.
Hadji, P., Aapro, M., Body, J., Gnant, M., Brandi, M., Reginster, J., Zillikens, M., Gluer, C., De Villiers, T., Baber, R., et al (2017). Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG. Journal of Bone Oncology, 7, 1-12. [More Information]
Bateson, D., Mazza, D., Frearson, M., Goldstone, P., Kovacs, G., Baber, R. (2017). Reply to ‘Response to Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion’. Australian and New Zealand Journal of Obstetrics and Gynaecology, 57(6), E16-E17. [More Information]
Baber, R. (2017). Sex hormones, receptors and modulators. Australian and New Zealand Journal of Obstetrics and Gynaecology, 57(4), 391-392. [More Information]
Baber, R., Panay, N., Fenton, A. (2016). 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric, 19(2), 109-150. [More Information]
Collins, P., Webb, C., De Villiers, T., Stevenson, J., Panay, N., Baber, R. (2016). Cardiovascular risk assessment in women - an update. Climacteric, 19(4), 329-336. [More Information]
Bateson, D., Butcher, B., Donovan, C., Farrell, L., Kovacs, G., Mezzini, T., Raynes-Greenow, C., Pecoraro, G., Read, C., Baber, R. (2016). Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis. Australian Family Physician, 45(1-2), 59-64.
Kornhaber, R., Betihavas, V., Baber, R. (2015). Ethical implications of digital images for teaching and learning purposes: an integrative review. Journal of Multidisciplinary Healthcare, 8, 299-305. [More Information]
Baber, R. (2015). Menopausal hormone therapy and ovarian cancer. Journal of Mid-Life Health, 6(3), 101-103. [More Information]
Shapiro, S., Stevenson, J., Mueck, A., Baber, R. (2015). Misrepresentation of the risk of ovarian cancer among women using menopausal hormones Spurious findings in a meta-analysis. Maturitas, 81(2), 323-326. [More Information]
Kornhaber, R., McLean, L., Baber, R. (2015). Ongoing ethical issues concerning authorship in biomedical journals: an integrative review. International Journal of Nanomedicine, 10, 4837-4846. [More Information]
Clifton-Bligh, P., Nery,, M., Clifton-Bligh, R., Visvalingam, S., Fulcher, G., Byth Wilson, K., Baber, R. (2015). Red clover isoflavones enriched with formononetin lower serum LDL cholesterol-a randomized, double-blind, placebo-controlled study. European Journal of Clinical Nutrition, 69(1), 134-142. [More Information]
Davis, S., Baber, R. (2015). Reproductive endocrinology: Menopausal hormone therapy-ovarian cancer risk revisited. Nature Reviews Endocrinology, 11(6), 322-323. [More Information]
Baber, R. (2015). Vulvovaginal atrophy - Or is it genitourinary syndrome of menopause? Medicine Today, 16(10), 65-68.
Baber, R. (2014). East is east and West is west: Perspectives on the menopause in Asia and the West. Climacteric, 17(1), 23-28. [More Information]
Baber, R. (2014). IMS 2014: the new President's view. Climacteric, 17(Suppl 2), 3-3. [More Information]
Baber, R. (2014). On aspirations. Climacteric, 17(3), 213-214. [More Information]
Lobo, R., Davis, S., De Villers, T., Gompell, A., Henderson, V., Hodis, H., Lumsden, M., Mack, W., Shapiro, S., Baber, R. (2014). Prevention of diseases after menopause. Climacteric, 17(5), 540-556. [More Information]
Baber, R. (2014). Primary ovarian insufficiency. Medicine Today, 15(3), 73-75.
Shapiro, S., DeVilliers, T., Pines, A., Sturdee, D., Archer, D., Baber, R., Panay, N., Farmer, R., Stevenson, J., Mueck, A., et al (2014). RE: Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study. Journal of the National Cancer Institute, 106(2), djt372-djt372. [More Information]
Shapiro, S., De Villiers, M., Pines, A., Sturdee, D., Baber, R., Panay, N., Stevenson, J., Mueck, A., BURGER, H. (2014). Risks and benefits of hormone therapy: Has medical dogma now been overturned? Climacteric, 17(3), 215-222. [More Information]
Cusack, L., Brennan, M., Baber, R., Boyle, F. (2013). Menopausal symptoms in breast cancer survivors: management update. British Journal of General Practice, 63(606), 51-52. [More Information]
Gompel, A., Baber, R., de Villiers, T., Huang, K., Santen, R., Shah, D., Villaseca, P., Shapiro, S. (2013). Oncology in midlife and beyond. Climacteric, 16(5), 522-535. [More Information]
de Villiers, T., Pines, A., Panay, N., Gambacciani, M., Archer, D., Baber, R., Davis, S., Gompell, A., Henderson, V., Langer, R., et al (2013). Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric, 16(3), 316-337. [More Information]
Baber, R. (2012). Breast cancer in postmenopausal women after hormone therapy. JAMA, 305(5), 466-467. [More Information]
Baber, R. (2012). Possible net harms of breast cancer screening. Climacteric, 15(4), 398-399. [More Information]
Archer, D., Sturdee, D., Baber, R., de Villiers, T., Pines, A., Freedman, R., Gompell, A., Hickey, M., Hunter, M., Lobo, R., et al (2011). Menopausal hot flushes and night sweats: where are we now? Climacteric, 14(5), 515-528. [More Information]
Sturdee, D., Pines, A., Baber, R., et al (2011). Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric, 14(3), 302-320. [More Information]
Baber, R. (2010). Phytoestrogens and post reproductive health. Maturitas, 66(4), 344-349. [More Information]
Huang, K., Baber, R. (2010). Updated clinical recommendations for the use of tibolone in Asian women. Climacteric, 13, 317-327. [More Information]
Patching van der Sluijs, C., Bensoussan, A., Chang, S., Baber, R. (2009). A randomized placebo-controlled trial on the effectiveness of an herbal formula to alleviate menopausal vasomotor symptoms. Menopause, 16(2), 336-344. [More Information]
Kenemans, P., Bundred, N., Foidart, J., Kubista, E., Von Schoultz, B., Sismondi, P., Vassilopoulou-Sellin, R., Yip, C., Egberts, J., Mol-Arts, M., Baber, R., et al (2009). Safety and effi cacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. The Lancet Oncology, 10, 135-146. [More Information]
Stuart, O., Morris, A., Baber, R. (2009). Vernix caseosa peritonitis - no longer rare or innocent: a case series. Journal of Medical Case Reports, 3, 60. [More Information]
Baber, R. (2007). HRT and Gynaecological Cancers. Menopausal Medicine, 14(3), S8-S12.
Nippita, T., Baber, R. (2007). Premature ovarian failure: a review. Climacteric, 10(1), 11-22. [More Information]
Nachtigall, L., Baber, R., Barentsen, R., Durand, N., Panay, N., Pitkin, J., van de Weijer, P., Wysocki, S. (2006). Complementary and Hormonal Therapy for Vasomotor Symptom Relief: A Conservative Clinical Approach. Journal of Obstetrics and Gynaecology Canada, 28(April), 279-289. [More Information]
Peeyananjarassri, K., Baber, R. (2005). Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric, 8(1), 13-23. [More Information]
Thewes, B., Meiser, B., Taylor, A., Phillips, K., Pendlebury, S., Capp, A., Dalley, D., Goldstein, D., Baber, R., Friedlander, M. (2005). Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. Journal of Clinical Oncology, 23(22), 5155-5165. [More Information]
Baber, R., Hickey, M., Kwik, M. (2005). Therapy for Menopausal Symptoms During and After Treatment for Breast Cancer. Safety Considerations. Drug Safety, 28(12), 1085-1100. [More Information]
Raja, C., Hansen, R., Baber, R., Allen, B. (2004). Hip Girth As A Predictor Of Abdominal Adiposity In Postmenopausal Women. Nutrition: an international journal of applied and basic nutritional science, 20(9), 772-777. [More Information]
Davis, S., O'Neill, S., Eden, J., Baber, R., Ekangaki, A., Stocks, J., Thiebaud, D. (2004). Transition From Estrogen Therapy To Raloxifene In Postmenopausal Women: Effects On Treatment Satisfaction And The Endometrium-A Pilot Study. Menopause, 11(2), 167-175. [More Information]
Hansen, R., Raja, C., Baber, R., Lieberman, D., Allen, B. (2003). Effects of 20-mg oestradiol implant therapy on bone mineral density, fat distribution and muscle mass in postmenopausal women. Acta Diabetologica, 40, S191-S195. [More Information]
Baber, R., O'Hara, J., Boyle, F. (2003). Hormone replacement therapy: to use or not to use? Medical Journal of Australia, 178(12), 630-633.
O'Neill, S., Eden, J., Baber, R., Ekangaki, A., Stocks, J., Wolthers, T., Davis, S. (2003). Transition to raloxifene with and without low-dose estrogen therapy in postmenopausal women: effects on serum lipids and fibrinogent - a pilot study. Climacteric, 6(4), 347-353. [More Information]
Ward, M., Morris, J., Baber, R., Visva-Lingam, S. (2002). The surgical management of postpartum haemorrhage: too little too late? Obstetrics and Gynecology, , 121-125.
Clifton-Bligh, P., Baber, R., Fulcher, G., Nery,, M., Moreton, T. (2001). The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause, 8, 259-265.

show 69 more

By Year

Expand all

2024

Whitton, K., Baber, R. (2024). Androgen-based therapies in women. Best Practice and Research: Clinical Endocrinology and Metabolism, 38(1), 101783. [More Information]
Whitton, K., Baber, R. (2024). Menopausal hormone therapy: Tips and pitfalls. Medicine Today, 25(9), 2-7.
Evans, S., Baber, R., Satyen, L., Skvarc, D., Mikocka-Walus, A., Van Niekerk, L., Orellana, L., O'shea, M., Druitt, M., Jones, S., et al (2024). The need for biopsychosocial menopause care: a narrative review. Menopause. [More Information]

2023

Hickey, M., Baber, R., Eden, J., Brennan, J., Bateson, D., Goldman, M. (2023). Safety and effectiveness of a novel home-use therapeutic ultrasound device for the treatment of vaginal dryness in postmenopausal women: a pilot study. Menopause, 30(4), 383-392. [More Information]
Yang, C., Eykman, E., Smith, C., Bacon, J., Morris, J., Baber, R., Seeho, S. (2023). Vernix Caseosa Peritonitis Causing Acute Abdomen After Cesarean Section: A Case Series. The American Journal of Case Reports, 24. [More Information]

2022

Magraith, K., Stuckey, B., Baber, R. (2022). Perimenopausal hormone therapy Assessment and prescribing. Medicine Today, 23(8), 61-66.
Ibiebele, I., Nippita, T., Baber, R., Torvaldsen, S. (2022). Pregnancy outcomes in women with endometriosis and/or ART use: a population-based cohort study. Human Reproduction, 37(10), 2350-2358. [More Information]
Vrselja, A., Latifi, A., Baber, R., Stuckey, B., Walker, M., Stearns, V., Hickey, M., Davis, S. (2022). Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet, 400(10364), 1704-1711. [More Information]
Davis, S., Baber, R. (2022). Treating menopause — MHT and beyond. Nature Reviews Endocrinology, 18(8), 490-502. [More Information]

show 1 more

2021

Ibiebele, I., Nippita, T., Baber, R., Torvaldsen, S. (2021). A study of pregnancy after endometrial ablation using linked population data. Acta Obstetricia et Gynecologica Scandinavica, 100(2), 286-293. [More Information]
Davis, S., Stuckey, B., Magraith, K., Baber, R. (2021). Letter to the Editor: "Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline". Journal of Clinical Endocrinology and Metabolism, 106(4), e1917-e1918. [More Information]
Rowe, I., Baber, R. (2021). The effects of phytoestrogens on postmenopausal health. Climacteric, 24(1), 57-63. [More Information]
Baber, R. (2021). Treating menopausal women: Have we lost our way? Australian and New Zealand Journal of Obstetrics and Gynaecology, 61(4), 493-495. [More Information]
de Villiers, T., Baber, R. (2021). Using menopausal hormone therapy to prevent fracture recurrence in older women: is it time to change our opinion? Climacteric, 24(4). [More Information]

show 2 more

2020

Davis, S., Baber, R., Panay, N., Pinkerton, J. (2020). Author's response to Letter to the Editor: Global Consensus Position Statement on the Use of Testosterone Therapy for Women"". Journal of Clinical Endocrinology and Metabolism, 105(6), dgaa126. [More Information]

2019

Davis, S., Baber, R., Panay, N., Bitzer, J., Perez, S., Islam, R., Kaunitz, A., Kingsberg, S., Lambrinoudaki, I., Liu, J., et al (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Sexual Medicine, 16(9), 1331-1337. [More Information]
Davis, S., Baber, R., Panay, N., Bitzer, J., Cerdas Perez, S., Islam, R., Kaunitz, A., Kingsberg, S., Lambrinoudaki, I., Liu, J., et al (2019). Global Consensus Position Statement on the use of Testosterone Therapy for Women. Maturitas, 128, 89-93. [More Information]
Davis, S., Baber, R., Panay, N., Bitzer, J., Cerdas Perez, S., Islam, R., Kaunitz, A., Kingsberg, S., Lambrinoudaki, I., Liu, J., et al (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology and Metabolism, 104(10), 4660-4666. [More Information]
Davis, S., Baber, R., Panay, N., Bitzer, J., Cerdas Perez, S., Islam, R., Kaunitz, A., Kingsberg, S., Lambrinoudaki, I., Liu, J., et al (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Climacteric, 22(5), 429-434. [More Information]
Baber, R. (2019). Premature menopause managing the long-term consequences. Medicine Today, 20(3), 45-47.

show 2 more

2018

Baber, R. (2018). Editor’s comment. Climacteric, 21(2), 197-197. [More Information]
Phua, C., Baber, R. (2018). The Management of Menopausal Symptoms in Women Following Breast Cancer: An Overview. Drugs & Aging, 35(8), 699-705. [More Information]
Baber, R. (2018). What's new in menopausal hormone therapy: Combination oestrogen-bazedoxifene. Medicine Today, 19(4), 47-50.

2017

Baber, R., Wright, J. (2017). A brief history of the International Menopause Society. Climacteric, 20(2), 85-90. [More Information]
Clifton-Bligh, P., Nery, M., Clifton-Bligh, R., Fulcher, G., Baber, R. (2017). Changes in bone mineral density related to changes in serum 25-OH vitamin D concentrations over a two-year period in postmenopausal women. Endocrine, 58(3), 587-590. [More Information]
Mazza, D., Bateson, D., Frearson, M., Goldstone, P., Kovacs, G., Baber, R. (2017). Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion. Australian and New Zealand Journal of Obstetrics and Gynaecology, 57(2), 206-212. [More Information]
Baber, R. (2017). Hormone therapy and menopause A protracted misunderstanding explained. Medicine Today, 18(2), 23-26.
Hadji, P., Aapro, M., Body, J., Gnant, M., Brandi, M., Reginster, J., Zillikens, M., Gluer, C., De Villiers, T., Baber, R., et al (2017). Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG. Journal of Bone Oncology, 7, 1-12. [More Information]
Bateson, D., Mazza, D., Frearson, M., Goldstone, P., Kovacs, G., Baber, R. (2017). Reply to ‘Response to Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion’. Australian and New Zealand Journal of Obstetrics and Gynaecology, 57(6), E16-E17. [More Information]
Baber, R. (2017). Sex hormones, receptors and modulators. Australian and New Zealand Journal of Obstetrics and Gynaecology, 57(4), 391-392. [More Information]

show 4 more

2016

Baber, R., Panay, N., Fenton, A. (2016). 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric, 19(2), 109-150. [More Information]
Collins, P., Webb, C., De Villiers, T., Stevenson, J., Panay, N., Baber, R. (2016). Cardiovascular risk assessment in women - an update. Climacteric, 19(4), 329-336. [More Information]
Bateson, D., Butcher, B., Donovan, C., Farrell, L., Kovacs, G., Mezzini, T., Raynes-Greenow, C., Pecoraro, G., Read, C., Baber, R. (2016). Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis. Australian Family Physician, 45(1-2), 59-64.

2015

Kornhaber, R., Betihavas, V., Baber, R. (2015). Ethical implications of digital images for teaching and learning purposes: an integrative review. Journal of Multidisciplinary Healthcare, 8, 299-305. [More Information]
Baber, R. (2015). Menopausal hormone therapy and ovarian cancer. Journal of Mid-Life Health, 6(3), 101-103. [More Information]
Shapiro, S., Stevenson, J., Mueck, A., Baber, R. (2015). Misrepresentation of the risk of ovarian cancer among women using menopausal hormones Spurious findings in a meta-analysis. Maturitas, 81(2), 323-326. [More Information]
Kornhaber, R., McLean, L., Baber, R. (2015). Ongoing ethical issues concerning authorship in biomedical journals: an integrative review. International Journal of Nanomedicine, 10, 4837-4846. [More Information]
Clifton-Bligh, P., Nery,, M., Clifton-Bligh, R., Visvalingam, S., Fulcher, G., Byth Wilson, K., Baber, R. (2015). Red clover isoflavones enriched with formononetin lower serum LDL cholesterol-a randomized, double-blind, placebo-controlled study. European Journal of Clinical Nutrition, 69(1), 134-142. [More Information]
Davis, S., Baber, R. (2015). Reproductive endocrinology: Menopausal hormone therapy-ovarian cancer risk revisited. Nature Reviews Endocrinology, 11(6), 322-323. [More Information]
Baber, R. (2015). Vulvovaginal atrophy - Or is it genitourinary syndrome of menopause? Medicine Today, 16(10), 65-68.

show 4 more

2014

Baber, R. (2014). East is east and West is west: Perspectives on the menopause in Asia and the West. Climacteric, 17(1), 23-28. [More Information]
Baber, R. (2014). IMS 2014: the new President's view. Climacteric, 17(Suppl 2), 3-3. [More Information]
Baber, R. (2014). On aspirations. Climacteric, 17(3), 213-214. [More Information]
Lobo, R., Davis, S., De Villers, T., Gompell, A., Henderson, V., Hodis, H., Lumsden, M., Mack, W., Shapiro, S., Baber, R. (2014). Prevention of diseases after menopause. Climacteric, 17(5), 540-556. [More Information]
Baber, R. (2014). Primary ovarian insufficiency. Medicine Today, 15(3), 73-75.
Shapiro, S., DeVilliers, T., Pines, A., Sturdee, D., Archer, D., Baber, R., Panay, N., Farmer, R., Stevenson, J., Mueck, A., et al (2014). RE: Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study. Journal of the National Cancer Institute, 106(2), djt372-djt372. [More Information]
Shapiro, S., De Villiers, M., Pines, A., Sturdee, D., Baber, R., Panay, N., Stevenson, J., Mueck, A., BURGER, H. (2014). Risks and benefits of hormone therapy: Has medical dogma now been overturned? Climacteric, 17(3), 215-222. [More Information]

show 4 more

2013

Cusack, L., Brennan, M., Baber, R., Boyle, F. (2013). Menopausal symptoms in breast cancer survivors: management update. British Journal of General Practice, 63(606), 51-52. [More Information]
Gompel, A., Baber, R., de Villiers, T., Huang, K., Santen, R., Shah, D., Villaseca, P., Shapiro, S. (2013). Oncology in midlife and beyond. Climacteric, 16(5), 522-535. [More Information]
de Villiers, T., Pines, A., Panay, N., Gambacciani, M., Archer, D., Baber, R., Davis, S., Gompell, A., Henderson, V., Langer, R., et al (2013). Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric, 16(3), 316-337. [More Information]

2012

Baber, R. (2012). Breast cancer in postmenopausal women after hormone therapy. JAMA, 305(5), 466-467. [More Information]
Baber, R. (2012). Possible net harms of breast cancer screening. Climacteric, 15(4), 398-399. [More Information]

2011

Archer, D., Sturdee, D., Baber, R., de Villiers, T., Pines, A., Freedman, R., Gompell, A., Hickey, M., Hunter, M., Lobo, R., et al (2011). Menopausal hot flushes and night sweats: where are we now? Climacteric, 14(5), 515-528. [More Information]
Sturdee, D., Pines, A., Baber, R., et al (2011). Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric, 14(3), 302-320. [More Information]

2010

Baber, R. (2010). Phytoestrogens and post reproductive health. Maturitas, 66(4), 344-349. [More Information]
Huang, K., Baber, R. (2010). Updated clinical recommendations for the use of tibolone in Asian women. Climacteric, 13, 317-327. [More Information]

2009

Patching van der Sluijs, C., Bensoussan, A., Chang, S., Baber, R. (2009). A randomized placebo-controlled trial on the effectiveness of an herbal formula to alleviate menopausal vasomotor symptoms. Menopause, 16(2), 336-344. [More Information]
Kenemans, P., Bundred, N., Foidart, J., Kubista, E., Von Schoultz, B., Sismondi, P., Vassilopoulou-Sellin, R., Yip, C., Egberts, J., Mol-Arts, M., Baber, R., et al (2009). Safety and effi cacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. The Lancet Oncology, 10, 135-146. [More Information]
Stuart, O., Morris, A., Baber, R. (2009). Vernix caseosa peritonitis - no longer rare or innocent: a case series. Journal of Medical Case Reports, 3, 60. [More Information]

2007

Baber, R. (2007). HRT and Gynaecological Cancers. Menopausal Medicine, 14(3), S8-S12.
Nippita, T., Baber, R. (2007). Premature ovarian failure: a review. Climacteric, 10(1), 11-22. [More Information]

2006

Nachtigall, L., Baber, R., Barentsen, R., Durand, N., Panay, N., Pitkin, J., van de Weijer, P., Wysocki, S. (2006). Complementary and Hormonal Therapy for Vasomotor Symptom Relief: A Conservative Clinical Approach. Journal of Obstetrics and Gynaecology Canada, 28(April), 279-289. [More Information]

2005

Peeyananjarassri, K., Baber, R. (2005). Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric, 8(1), 13-23. [More Information]
Thewes, B., Meiser, B., Taylor, A., Phillips, K., Pendlebury, S., Capp, A., Dalley, D., Goldstein, D., Baber, R., Friedlander, M. (2005). Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. Journal of Clinical Oncology, 23(22), 5155-5165. [More Information]
Baber, R., Hickey, M., Kwik, M. (2005). Therapy for Menopausal Symptoms During and After Treatment for Breast Cancer. Safety Considerations. Drug Safety, 28(12), 1085-1100. [More Information]

2004

Raja, C., Hansen, R., Baber, R., Allen, B. (2004). Hip Girth As A Predictor Of Abdominal Adiposity In Postmenopausal Women. Nutrition: an international journal of applied and basic nutritional science, 20(9), 772-777. [More Information]
Davis, S., O'Neill, S., Eden, J., Baber, R., Ekangaki, A., Stocks, J., Thiebaud, D. (2004). Transition From Estrogen Therapy To Raloxifene In Postmenopausal Women: Effects On Treatment Satisfaction And The Endometrium-A Pilot Study. Menopause, 11(2), 167-175. [More Information]

2003

Hansen, R., Raja, C., Baber, R., Lieberman, D., Allen, B. (2003). Effects of 20-mg oestradiol implant therapy on bone mineral density, fat distribution and muscle mass in postmenopausal women. Acta Diabetologica, 40, S191-S195. [More Information]
Baber, R., O'Hara, J., Boyle, F. (2003). Hormone replacement therapy: to use or not to use? Medical Journal of Australia, 178(12), 630-633.
O'Neill, S., Eden, J., Baber, R., Ekangaki, A., Stocks, J., Wolthers, T., Davis, S. (2003). Transition to raloxifene with and without low-dose estrogen therapy in postmenopausal women: effects on serum lipids and fibrinogent - a pilot study. Climacteric, 6(4), 347-353. [More Information]

2002

Ward, M., Morris, J., Baber, R., Visva-Lingam, S. (2002). The surgical management of postpartum haemorrhage: too little too late? Obstetrics and Gynecology, , 121-125.

2001

Clifton-Bligh, P., Baber, R., Fulcher, G., Nery,, M., Moreton, T. (2001). The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause, 8, 259-265.

Faculty of Medicine and Health

Page not found

Professor Rodney Baber

Publications

By Type

By Year